XORTX Therapeutics Inc (XRTX)

US · Healthcare · Biotechnology

$1.24-12.68%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-1.7M

EPS

$-1.05

Market cap

$2.6M

Forward P/E

1.0

P/B

0.56

Book value

$1.50

EPS (TTM)

$-2.61

52-week high

$7.05

52-week low

$1.36

50-day MA

$2.02

200-day MA

$2.26

Beta

0.58

with an average price target of $14.04.

Insiders

1.53%

Institutions

0.01%

Fund	Stake
Citadel Advisors Llc	1.27%
StoneX Group Inc	0.90%
Royal Bank of Canada	0.04%
NATIONAL BANK OF CANADA /FI/	0.01%
Hartland & Co	0.00%
TD Waterhouse Canada Inc	0.00%
DRW Securities, LLC	0.00%
Kingsview Wealth Management, LLC	0.00%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for XORTX Therapeutics Inc — free to start.

Data updated 2026-10-18.